Pharmafile Logo
Pharmafocus logo
Advanced Search

Gilead

Showing 15 posts of 244 posts found.

gilead-sciences

FDA gives approval for Gilead’s hepatitis C therapy

July 19, 2017
Research and Development, Sales and Marketing FDA, Gilead, US, Vosevi, biotech, drugs, healthcare, pharma, pharmaceutical

The FDA has announced that it has chosen to approve Vosevi (sofosbuvir/velpatasvir/voxilaprevir), Gilead’s investigational drug for the treatment of chronic …

News
gilead-sciences

Gilead to launch injunction against Mylan and Actavis over HIV generics in Ireland

July 6, 2017
Sales and Marketing Actavis, Gilead, HIV, Mylan, Truvada

Gilead is expected to launch injunctive action against rivals Mylan and Actavis over the allegation that they are planning to …

News
handshake

Amygdala acquires Gilead’s candidate for addiction treatment

February 20, 2017
Manufacturing and Production, Sales and Marketing Amygdala, Gilead

Amygdala Neurosciences, a biopharmaceutical company that develops and commercialises drugs for the treatment of addiction disorders, has agreed an acquisition …

News
down_arrow

Hepatitis C market set for slump as cure rates rise

February 14, 2017
Manufacturing and Production, Medical Communications, Sales and Marketing Gilead, hepatitis C

Objectively, it is the pharmaceutical industries intention to find cures for diseases and to aid patients to live a full …

News
alessandro-riva

Gilead makes move in oncology by snaffling Riva from Novartis

January 4, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, Novartis, oncology

Gilead Sciences have made an ambitious move to boost its oncology business by appointing current head of global oncology development …

Appointment
nhs_trees

Court of Appeal rules that the NHS can legally fund HIV-prevention drug PrEP

November 10, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Court of Appeals, Gilead, NHS England, Truvada, high court

A High Court ruling that NHS England was legally responsible for preventing the spread of HIV has been upheld when …

News
gilead-sciences

Gilead quietly drops drugs from line up alongide Q3 results

November 2, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abzena, Gilead, research and development

Gilead Sciences followed Pfizer in discreetly dropping a drug alongside its third quarter profit reports. The drug in question, for …

News
gilead-sciences

Gilead’s drug boosted by positive Phase II trials and aims to move forward

October 21, 2016
Medical Communications Gilead, Gilead Sciences, clinical trials, fatty liver disease

Gilead Sciences has announced positive results from three Phase II studies upon their drug GS-4997, otherwise known as selonsertib. The …

News
gilead-sciences

Gilead terminates Phase II/III study for ulcerative colitis antibody

September 22, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, ulcerative colitis

Gilead has put the brakes on a Phase II/III study of its anti-MMP9 antibody GS-5745 for the treatment of ulcerative …

News
4420456374_64a3d7e6aa

Top Ten articles in the Pharma Industry this week

September 16, 2016
Medical Communications Bayer, GSK, Gilead, GlaxoSmithKline, J&J, JJ, Pfizer, Roche, Sanofi, Takeda, aspen, google, monsanto

As we come to the end of another week, we’re looking back at an exciting week in the industry; there …

News
afd-69766

Gilead appoints former Roche executive

September 9, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, Roche, appointment

Gilead Sciences has hired Rogers Luo as vice president and general manager of commercial operations in China. Luo formerly served …

Appointment
gilead-sciences

Gilead gets EU approval for HIV-prevention treatment Truvada

August 23, 2016
Manufacturing and Production, Sales and Marketing EU, Gilead, HIV, PrEP, Truvada, prevention

Gilead Sciences has received marketing authorisation from the European Commission for once-daily Truvada (emtricitabine/tenofovir disoproxil), in combination with safer sex …

News
gilead-sciences

Gilead to work with Genmab on HIV targeting technology

August 12, 2016
Medical Communications, Research and Development, Sales and Marketing Genmab, Gilead, HIV, duobody

Genmab has announced that it has entered into a collaboration deal with Gilead Sciences to use the DuoBody technology platform …

News
gilead-sciences

Gilead lowers full-year guidance as sales and profits down in Q2

July 26, 2016
Manufacturing and Production, Research and Development, Sales and Marketing 2016, Gilead, Q2, results

Gilead Sciences has announced its financial results from the second quarter of this year, with sales and profits taking a …

News
abbvie_0

AbbVie scores EU recommendation for shorter treatment of Viekirax in hepatitis C

July 25, 2016
Research and Development, Sales and Marketing EU, Gilead, Viekirax, hepatitis C

AbbVie has received an EU recommendation for a shorter treatment duration of Viekirax (ombitasvir/paritaprevir/ritonavir) plus ribavirin in genotype 4 chronic …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025